The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
VM

v.milanovi

TL3 Regular · Montpellier, FR

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 24 August 2024 · last posted 13h

132Posts here
2Topics
1Solutions
512Likes received
558Likes given
22Badges
241Days visited
2.4kPosts read

Most-liked posts

  • MHRA statements, read directly Started this topic · Regional › UK & Ireland · 4 Sep 2025 · 47 likes MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
  • What I would record differently if I started again — the long version Started this topic · Outcomes › Progress reports · 22 May 2025 · 38 likes What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below.…
  • Pen dose counters: what a click does and does not guarantee Replied, post #87 · Devices › Pens & autoinjectors · 18 Nov 2025 · 33 likes post #86 answers the question as asked. The question underneath it is different. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
  • Second pass at: Identical chromatograms across two different lots Replied, post #40 · Sourcing › Red flags · 3 Mar 2026 · 32 likes post #39 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
  • Carryover and the ghost peak from last week's standard — what changed since Replied, post #31 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 31 likes This follows post #28 rather than contradicting it. System suitability testing: injections run before and during the sample run to establish whether the instrument,…
  • Athletes in weight-category sports: a different risk calculus Replied, post #19 · Clinical › Special populations · 9 Jul 2026 · 30 likes This follows post #16 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…

Where this member posts

CategoryPostsShare
Compounds2015%
Sourcing1713%
Analytics1511%
Practice1511%
Evidence1411%
Clinical65%

Badges earned, in order

BadgeTierGranted
First Replybronze26 Aug 2024
Basic Userbronze28 Aug 2024
Read the Guidelinesbronze30 Aug 2024
First Linkbronze30 Aug 2024
Welcomebronze13 Sep 2024
First Topicbronze14 Sep 2024
Memberbronze15 Sep 2024
First Quotebronze26 Sep 2024
Readerbronze29 Sep 2024
First Tagbronze2 Oct 2024
Nice Topicbronze11 Oct 2024
Sourcedbronze8 Nov 2024
Generousbronze16 Nov 2024
Thank Yousilver6 Dec 2024
Editorbronze22 Dec 2024
Well Sourcedsilver6 Jan 2025
First Solutionbronze17 Jan 2025
Good Topicsilver24 Jan 2025
Regularsilver30 Jan 2025
Good Postsilver5 Feb 2025
Nice Postbronze3 Mar 2025
Anniversarysilver24 Aug 2025